Yayınlar & Eserler

Yayın Ağı
Makaleler 14
Tümü (14)
SCI-E, SSCI, AHCI (10)
SCI-E, SSCI, AHCI, ESCI (12)
ESCI (2)
Scopus (13)
TRDizin (3)

1. Formulation Optimization and in Vitro-in Vivo Evaluation of Alpha Lipoic Acid-Loaded Lipid-Polymer Hybrid Nanoparticles Via Design of Experiments

ÇOBAN Ö., DEMİRTAŞ H., KAYA YAŞAR Y., ENGİN S., YILDIRIM S., Morsali M. R.
JOURNAL OF PHARMACEUTICAL INNOVATION , cilt.20, sa.2, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

2. Preparation and evaluation of sertraline-loaded bovine serum albumin nanoparticles via multilevel categorical and D-optimal designs

Coban O., SAYLAM N., Baran E. S., Kucuktemel L.
JOURNAL OF RESEARCH IN PHARMACY , cilt.29, sa.6, ss.2317-2326, 2025 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

3. Evaluation of Different Methods for Dissolution Profile Similarity Comparison of Montelukast Tablets in Türkiye

ÇOBAN Ö., Usta D. Y., Pinar S. G.
Dissolution Technologies , cilt.31, sa.1, ss.40-49, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

4. Preparation and Characterisation of Liposomal Formulations of Levamisole and Albendazole Used in Veterinary Medicine Preparación y caracterización de formulaciones liposomales de levamisol y albendazol utilizadas en medicina veterinaria

Susar H., Çelebi M., Çelebi Ç., Çoban Ö., Şen H., Karahan İ.
Revista Cientifica de la Facultad de Veterinaria , cilt.34, sa.2, 2024 (SCI-Expanded, Scopus) identifier

5. The Preparation of Liposomal Formulations of Gentamicin and Ceftiofur Used in Veterinary Medicine

SUSAR H., ÇELEBİ M., ÇELEBİ Ç., ÇOBAN Ö., ŞEN H., KARAHAN I.
Balıkesir Sağlık Bilimleri Dergisi (BSBD) , cilt.12, sa.3, ss.554-559, 2023 (TRDizin) identifier

6. Alpha-Lipoic Acid and Cyanocobalamin Co-Loaded Nanoemulsions: Development, Characterization, and Evaluation of Stability

ÇOBAN Ö., YILDIRIM S., Bakir T.
JOURNAL OF PHARMACEUTICAL INNOVATION , cilt.17, sa.2, ss.510-520, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

7. Colon targeted delivery of niclosamide from β-cyclodextrin inclusion complex incorporated electrospun Eudragit® L100 nanofibers

ÇOBAN Ö., Aytac Z., Yildiz Z. I., Uyar T.
Colloids and Surfaces B: Biointerfaces , cilt.197, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

8. Development and in vitro evaluation of BSA-coated liposomes containing Zn (II) phthalocyanine-containing ferrocene groups for photodynamic therapy of lung cancer

ÇOBAN Ö., Barut B., YALÇIN C. Ö., ÖZEL A., BIYIKLIOĞLU Z.
Journal of Organometallic Chemistry , cilt.925, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

9. Synthesis, DNA interaction, in vitro/in silico topoisomerase II inhibition and photodynamic therapy activities of two cationic BODIPY derivatives

Barut B., COBAN O., YALÇIN C. Ö., Bas H., SARI S., Biyiklioglu Z., et al.
DYES AND PIGMENTS , 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

10. Development and validation of highly selective method for the determination of imatinib mesylate and dexketoprofen trometamol combination in three different media

ÇOBAN Ö., Degim Z.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.56, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

11. Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties

Barut B., YALÇIN C. Ö., SARI S., ÇOBAN Ö., Keles T., BIYIKLIOĞLU Z., et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.183, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

12. Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma

Coban Ö., Degim Z., Yilmaz S., Altintas L., Arsoy T., SÖZMEN M.
DRUG DEVELOPMENT RESEARCH , cilt.80, sa.5, ss.556-565, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

13. Development of Nanocochleates Containing Erlotinib HCl and Dexketoprofen Trometamol and Evaluation of In Vitro Characteristic Properties

ÇOBAN Ö., Degim Z.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.15, sa.1, ss.16-21, 2018 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier

14. Liposomes Containig Imatinib Mesylate and Dexketoprofen Trometamol Development and Characterization

ÇOBAN Ö., DEĞİM Z.
FABAD Journal of Pharmaceutical Sciences , cilt.38, sa.3, ss.121-126, 2016 (Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 11

1. NICLOSAMIDE LOADED NIOSOME FOR TOPICAL APPLICATIONS: DEVELOPMENT AND IN VITRO CHARACTERIZATION

Yetgin C., Çıtlak H., Çoban Ö.
ISOPS-2021 (13th International Symposium on Pharmaceutical Sciences), Ankara, Türkiye, 22 - 25 Haziran 2021, (Özet Bildiri) Creative Commons License

2. Introducing Boron Nitride Nanotubes to Drug Delivery Platform for The Treatment of Cancer

TUNA S., DEMİRBOLAT G. M., ÇOBAN Ö., ALTINTAŞ L., YILMAZ Ş., ARSOY T., et al.
BIO TURKİYE-ULUSLARARASI BİYOTEKNOLOJİ KONGRESİ, 5 - 07 Mart 2020 Sürdürülebilir Kalkınma

3. Photodynamic activity properties of novel BODIPY compound againist colorectal cancer cell line

BARUT B., YALÇIN C. Ö., SARI S., ÇOBAN Ö., KELEŞ T., BIYIKLIOĞLU Z., et al.
XXX.National Congress of The Turkish Biochemical Society, Antalya, Türkiye, 27 - 31 Ekim 2019, (Özet Bildiri)

4. Evaluatıon of The Anticancer Activities of Liposomal Zinc(II) Phthalocyanine Bearing Ferrocene Groups and Erlotinib on A549 Cancer Cell Line

ÇOBAN Ö., BARUT B., YALÇIN C. Ö., ÖZEL A., BIYIKLIOĞLU Z.
8th BBBB International Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, ss.62, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

5. pH-dependent release of niclosamide loaded Eudragit nanofibers for colon targeting:formulation development and in vitro characterization studies

ÇOBAN Ö., AYTAÇ Z., YILDIZ Z. İ., UYAR T.
EUFEPS Annual Meeting 2019, 6 - 08 Mart 2019, (Tam Metin Bildiri)

6. In Vitro/In Vivo Evaluation of Folate Receptor Targeted Liposomes and NanocochleatesContaining Imatinib-Dexketoprofen for the Treatment of Fibrosarcoma

ÇOBAN Ö., DEĞİM Z., SÖZMEN M., ALTINTAŞ L., YILMAZ Ş., ARSOY T.
EUFEPS Annual Meeting 2018 Crossing Barriers for Future Medicines, Athena, Yunanistan, 24 Mayıs - 26 Ocak 2018, (Özet Bildiri)

7. USING LIPOSOMES CONTAINING ERLOTINIB-DEXKETOPROFENFOR THE TREATMENT OF CANCER

DEĞİM Z., ÇOBAN Ö.
GPSS, 11 - 13 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

8. Erlotinib Liposomes And Nanocochleates

ÇOBAN Ö., DEĞİM Z.
International Gazi Pharma Symposium Series, Antalya, Türkiye, 12 - 15 Kasım 2015

9. Development of a Nanocarrier Sytem containing Combination of Drugs Erlotinib Dexketoprofen forEffective Anticancer Therapy

DEMİR G. M., ÇOBAN Ö., sema t. t., DEĞİM Z., DEĞİM İ. T.
American Association of Pharmaceutical Scientists, Orlando, Amerika Birleşik Devletleri, 25 - 29 Ekim 2015

10. Simultaneous Determination of Imatinib Mesylate and Dexketoprofen Trometamol Using UPLC

ÇOBAN Ö., DEMİR G. M., sema t. t., DEĞİM Z., DEĞİM İ. T.
International symposium on pharmaceutical sciences, Ankara, Türkiye, 9 - 11 Haziran 2015

11. Stirring Speed Effects on Physical Characteristics of Theophylline Microsphere

ÇOBAN Ö., DEĞİM Z., DEMİRBOLAT G. M., KARAKÜÇÜK A. E., Bektaş D., Tuna Torunoğlu S., et al.
. 5th International Conference on Nanotechnology: Fundamentals and Application, 11 - 13 Ağustos 2014, (Özet Bildiri)
Metrikler

Yayın

29

Yayın (WoS)

13

Yayın (Scopus)

14

Atıf (WoS)

80

H-İndeks (WoS)

4

Atıf (Scopus)

81

H-İndeks (Scopus)

4

Atıf (Scholar)

70

H-İndeks (Scholar)

3

Proje

15

Fikri Mülkiyet

1

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları